Related references
Note: Only part of the references are listed.Antidepressant-like effect of guanosine involves activation of AMPA receptor and BDNF/TrkB signaling
Priscila B. Rosa et al.
PURINERGIC SIGNALLING (2021)
A single administration of ascorbic acid rapidly reverses depressive-like behavior and hippocampal synaptic dysfunction induced by corticosterone in mice
Daiane B. Fraga et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Ascorbic acid presents rapid behavioral and hippocampal synaptic plasticity effects
Daiane B. Fraga et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Guanosine fast onset antidepressant-like effects in the olfactory bulbectomy mice model
Roberto Farina de Almeida et al.
SCIENTIFIC REPORTS (2020)
Guanosine potentiates the antidepressant-like effect of subthreshold doses of ketamine: Possible role of pro-synaptogenic signaling pathway
Anderson Camargo et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Subthreshold doses of guanosine plus ketamine elicit antidepressant-like effect in a mouse model of depression induced by corticosterone: Role of GR/NF-κB/IDO-1 signaling
Anderson Camargo et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
mTORC1-dependent signaling pathway underlies the rapid effect of creatine and ketamine in the novelty-suppressed feeding test
Francis L. Pazini et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Ketamine, but not guanosine, as a prophylactic agent against corticosterone-induced depressive-like behavior: Possible role of long-lasting pro-synaptogenic signaling pathway
Anderson Camargo et al.
EXPERIMENTAL NEUROLOGY (2020)
The involvement of PI3K/Akt/mTOR/GSK3β signaling pathways in the antidepressant-like effect of AZD6765
Vivian B. Neis et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and neuroprotective activities
Ana Lucia Bertarello Zeni et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Oleanolic acid decreases SGK1 in the hippocampus in corticosterone-induced mice
Shu-Qi Dong et al.
STEROIDS (2019)
Lower synaptic density is associated with depression severity and network alterations
Sophie E. Holmes et al.
NATURE COMMUNICATIONS (2019)
Augmentation effect of ketamine by guanosine in the novelty-suppressed feeding test is dependent on mTOR signaling pathway
Anderson Camargo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2019)
The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways
Priscila B. Rosa et al.
PURINERGIC SIGNALLING (2019)
Involvement of PI3K/Akt/GSK-3β signaling pathway in the antidepressant-like and neuroprotective effects of Morus nigra and its major phenolic, syringic acid
Ana Paula Dalmagro et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Gallic acid activates hippocampal BDNF-Akt-mTOR signaling in chronic mild stress
Ji-Xiao Zhu et al.
METABOLIC BRAIN DISEASE (2019)
Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats
Martin Hadamitzky et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine
Vivian B. Neis et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine
Rong-Jian Liu et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies
Gonzalo S. Tejeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice
Andiara E. Freitas et al.
MOLECULAR NEUROBIOLOGY (2016)
Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway
Francis L. Pazini et al.
MOLECULAR NEUROBIOLOGY (2016)
Ketamine use in current clinical practice
Mei Gao et al.
ACTA PHARMACOLOGICA SINICA (2016)
Novel approaches for the management of depressive disorders
Manuella P. Kaster et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice
Lianjin Weng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Reduced Global Functional Connectivity of the Medial Prefrontal Cortex in Major Depressive Disorder
James W. Murrough et al.
HUMAN BRAIN MAPPING (2016)
Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims
Anna Rafalo-Ulinska et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
G. I. Papakostas et al.
MOLECULAR PSYCHIATRY (2015)
Glucocorticoid actions on synapses, circuits, and behavior: Implications for the energetics of stress
Brent Myers et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: A multi-center, naturalistic study
Changsu Han et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
The effects of chronic stress on hippocampal adult neurogenesis and dendritic plasticity are reversed by selective MAO-A inhibition
Monica Morais et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice
Priscila B. Rosa et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
Bhavya Voleti et al.
BIOLOGICAL PSYCHIATRY (2013)
Role of Prefrontal Cortex Glucocorticoid Receptors in Stress and Emotion
Jessica M. McKlveen et al.
BIOLOGICAL PSYCHIATRY (2013)
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects
Vanja Duric et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice
Yukio Ago et al.
NEUROPHARMACOLOGY (2013)
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Systematic correlation between spine plasticity and the anxiety/depression-like phenotype induced by corticosterone in mice
Guohua Wang et al.
NEUROREPORT (2013)
Effects of ketamine and LY341495 on the depressive-like behavior of repeated corticosterone-injected rats
Hiroyuki Koike et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test
Michihiko Iijima et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways
Luis E. B. Bettio et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Brian Magnuson et al.
BIOCHEMICAL JOURNAL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine–nitric oxide–cyclic guanosine monophosphate pathway and increases BDNF levels
Fabiana K. Ludka et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Decreased expression of synapse-related genes and loss of synapses in major depressive disorder
Hyo Jung Kang et al.
NATURE MEDICINE (2012)
CHRONIC INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN BY RAPAMYCIN MODULATES COGNITIVE AND NON-COGNITIVE COMPONENTS OF BEHAVIOR THROUGHOUT LIFESPAN IN MICE
J. Halloran et al.
NEUROSCIENCE (2012)
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
Ronald S. Duman et al.
TRENDS IN NEUROSCIENCES (2012)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Courtney S. Jernigan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
CHRONIC FLUOXETINE TREATMENT INDUCES STRUCTURAL PLASTICITY AND SELECTIVE CHANGES IN GLUTAMATE RECEPTOR SUBUNITS IN THE RAT CEREBRAL CORTEX
E. Ampuero et al.
NEUROSCIENCE (2010)
Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: Relevance to depression
Erin Y. Sterner et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
The varying effects of short-term and long-term corticosterone injections on depression-like behavior in mice
Yunan Zhao et al.
BRAIN RESEARCH (2009)
Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression
Denis J. David et al.
NEURON (2009)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS
P Willner
NEUROPSYCHOBIOLOGY (2005)
Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test
SC Dulawa et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Chronic stress attenuates glucocorticoid negative feedback: Involvement of the prefrontal cortex and hippocampus
K Mizoguchi et al.
NEUROSCIENCE (2003)
Stress and depression: possible links to neuron death in the hippocampus
AL Lee et al.
BIPOLAR DISORDERS (2002)
Morning cortisol as a risk factor for subsequent major depressive disorder in adult women
TO Harris et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents
IM Goodyer et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
